
Join to View Full Profile
725 Albany Street Suite 8aShapiro BldgBoston, MA 02118
Phone+1 617-638-7460
Fax+1 617-638-7454
Dr. Surmachevska is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Natalya Surmachevska, DO, is a rheumatologist based in Boston, MA. She completed her residency in Internal Medicine from 2018 to 2021 at UMass Chan Medical School, after graduating in 2018 from Lake Erie College of Osteopathic Medicine - Seton Hill. Her publications include works on COVID-19 associated oligoarthritis, senescence in osteoarthritis, and CAR-T cell therapy in systemic lupus erythematosus, with articles appearing in journals such as Clinical Immunology Communications, European Journal of Rheumatology, and ACR Open Rheumatology. One of her studies on seronegative inflammatory oligoarthritis associated with COVID-19 has been cited nine times.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Rheumatology, 2021 - 2024
- UMass Chan Medical SchoolResidency, Internal Medicine, 2018 - 2021
- Lake Erie College of Osteopathic Medicine - Seton HillClass of 2018
Certifications & Licensure
- MA State License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Erratum to "A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection" Clinical Immunology Communications 2 (2022) 159-161/.Lily H Sung, Natalya Surmachevska, Jose E Rubio
Clinical Immunology Communications. 2023-12-01 - Senescence in Osteoarthritis: Overview of Mechanisms and Therapeutics.Natalya Surmachevska, Jose Rubio
European Journal of Rheumatology. 2023-11-28 - Journal Club: Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus.Afroditi Boulougoura, Hannah Gendelman, Natalya Surmachevska, Vasileios C Kyttaris
ACR Open Rheumatology. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: